Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWZRA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $143,371
Award facts
- Contract value 100% obligated
- $143,370.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $143,370.64 under a firm fixed-price contract type. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025.
This procurement supports the federal healthcare supply chain by delivering Dupixent (dupilumab), a biologics treatment commonly used for allergic and inflammatory conditions, to military and federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills a broad spectrum of pharmaceutical products and medical supplies through its comprehensive DLA contract vehicle. The SPE2DX IDC serves as a global pharmaceutical support mechanism enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DB25FWZRA?
SPE2DB25FWZRA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FWZRA worth?
The government has obligated $143,371 on SPE2DB25FWZRA.
Is contract SPE2DB25FWZRA an order under another contract?
Yes. SPE2DB25FWZRA is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZRA competed?
The extent of competition for SPE2DB25FWZRA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award